Robinson Pharma has spent close to $170 million on buying local industrial properties since the start of 2020, records indicate. However, soon after buying the property, the group was approached by Robinson Pharma, and pivoted in its plans, Strader said. Dave Desper of CBRE represented Robinson Pharma in the sale, while CBRE’s Chip Wright represented the sellers. Robinson Pharma says it can also make up to 7 billion gummies annually. August 2026: Softgel manufac-turer Robinson Pharma completes $75 million purchase of the 2323 Main building.